Getting you a comprehensive review of the product
Reading every ingredient in the formula…
Reading every ingredient in the formula…
Join The Clean Sheet™ community
Science-backed beauty tips, ingredient alerts, and early access. Straight to your WhatsApp.
Join for free →
An encapsulated retinol night serum at a brand-confirmed 0.15% in an emulsion base. The encapsulation system uses Poloxamer 235, a block copolymer that protects retinol from premature degradation and enables slower, more controlled release into the skin - reducing the irritation typically associated with free retinol. EGCG (Epigallocatechin Gallate) from green tea provides anti-inflammatory support. Niacinamide at position 19 adds a synergistic anti-ageing mechanism. Diethylamino Hydroxybenzoyl Hexyl Benzoate (Uvinul A Plus, position 21) - a UV filter - appears in this night product specifically to photostabilise the retinol in the packaging, not as a skin UV filter. BHT and BHA (Butylated Hydroxytoluene and Butylated Hydroxyanisole) are antioxidant stabilisers at trace positions.
₹599 · ₹20/ml • Analysed 11 June 2026
Retinol at 0.15% via an encapsulated delivery system is appropriate for first-time retinol users, and particularly relevant for Indian skin: darker skin tones (Fitzpatrick IV-VI) carry higher PIH risk from retinol-induced irritation, so a controlled-release, lower-concentration entry point reduces this risk significantly. Apply at night only. Mandatory SPF 30+ the next morning. India's heat accelerates retinol degradation in open packaging - close immediately after use.
Independent and free. The Clean Sheet takes no money from brands to review, rank, or approve a product. This is a web evidence review, not a Clean Sheet certification. We checked the ingredient list, publicly available test reports, marketing claims, and formula logic using only public information available at the time of review.
Brand-confirmed; Poloxamer 235 encapsulation system disclosed.
Based on encapsulation supplier data, not an independent published trial for this formula.
Pregnancy contraindication is communicated on packaging - correct and necessary.
How we read this product across 5 areas. Open any row for the full rationale.
Retinol at 0.15% is below the EU guideline limit of 0.3% for face leave-on products. All retinoids carry a mandatory pregnancy contraindication. BHT and BHA at near-final positions are antioxidant stabilisers within permitted limits - these are not preservatives. Allergen Free Fragrance (synthetic, not fragrance-free) is present. Diethylamino Hydroxybenzoyl Hexyl Benzoate (Uvinul A Plus) is used here as an in-bottle retinol photostabiliser, not as a skin-applied UV filter. Cyclopentasiloxane and Dimethicone in the emulsion base have a good skin safety profile.
Encapsulated retinol via Poloxamer 235 is a meaningful delivery advance: the copolymer shell protects retinol from oxidation in storage and releases it progressively on skin...
Encapsulated retinol via Poloxamer 235 is a meaningful delivery advance: the copolymer shell protects retinol from oxidation in storage and releases it progressively on skin contact, achieving comparable efficacy to free retinol with significantly reduced irritation. EGCG from green tea at position 13 has anti-inflammatory clinical evidence relevant to the retinisation adjustment period. Niacinamide at position 19 adds independent collagen-supporting and brightening mechanisms. The emulsion base is appropriate for a retinol delivery vehicle.
Good evidence for stated claims based on public information.
Retinol at 0.15% is brand-confirmed. The Poloxamer 235 encapsulation system is disclosed on the product page - above-average transparency for an Indian brand. The '2x faster than regular retinol' claim for encapsulated delivery is based on supplier-commissioned studies, not independent peer-reviewed trials. Pregnancy contraindication is communicated on packaging.
“0.15% Retinol (Encapsulated)” Brand-confirmed; Poloxamer 235 encapsulation system disclosed.
“2x faster than regular retinol” Based on encapsulation supplier data, not an independent published trial for this formula.
“Not suitable during pregnancy” Pregnancy contraindication is communicated on packaging - correct and necessary.
No independent clinical study has been published for this formula. The '2x faster than regular retinol' claim references encapsulation technology supplier data, not an independent trial for this specific product. Retinol 0.15% is brand-confirmed. Encapsulation mechanism is disclosed.
Retinol at 0.15% is clearly stated. Pregnancy contraindication is communicated. The Poloxamer 235 encapsulation is explained. Uvinul A Plus's role as an in-bottle stabiliser (not a skin SPF) is not explained to consumers - potentially confusing given its presence in a night product.
| Ingredient |
|---|
Aqua |
Propylene Glycol |
Dicaprylyl Carbonate |
Dimethicone |
Caprylic/Capric Triglyceride |
Cetearyl Olivate |
Sorbitan Olivate |
Glyceryl Monostearate |
Propanediol |
Behenyl Alcohol |
Retinol |
Poloxamer 235 |
Epigallocatechin Gallate |
Polysorbate 20 |
BHT |
BHA |
Sodium Ascorbate |
Betaine |
Niacinamide |
Garcinia Indica Seed Butter |
Diethylamino Hydroxybenzoyl Hexyl Benzoate |
Polymethylsilsesquioxane |
Phenoxyethanol |
Tocopherol |
Allantoin |
Palmitoyl Glycine |
Sodium Hyaluronate |
Ethylhexylglycerin |
Octenidine HCl |
Ammonium Acryloyldimethyltaurate/VP Copolymer |
Disodium EDTA |
Sodium Hydroxide |
Allergen Free Fragrance |
INCI order as declared on packaging. Position reflects approximate concentration (high to low).
No banned substances; Allergen Free Fragrance formulated to exclude 26 EU-listed allergens per Regulation 2023/1545
No flagged substances
No flagged substances
No flagged substances
No flagged substances
No flagged substances
No flagged substances
No flagged substances
No flagged substances
No flagged substances
Flags are based on publicly available INCI only. Not a substitute for full regulatory compliance review.
Brand-confirmed; Poloxamer 235 encapsulation system disclosed.
Evidence visible
Based on encapsulation supplier data, not an independent published trial for this formula.
Mentioned only
Pregnancy contraindication is communicated on packaging - correct and necessary.
Evidence visible
Public evidence the brand could provide to close verification gaps
A thoughtfully designed beginner retinol serum. The encapsulated delivery via Poloxamer 235 is a genuine formulation advantage for Indian skin, where retinol-associated PIH from irritation is a real risk for darker Fitzpatrick types. Pregnancy contraindication and nighttime-only use guidance are clearly communicated.
Are you the brand? If you have published test data or want to request a re-review, write to us at hello@thecleansheet.in.
How we read this product across 5 areas. Open any row for the full rationale.
Retinol at 0.15% is below the EU guideline limit of 0.3% for face leave-on products. All retinoids carry a mandatory pregnancy contraindication. BHT and BHA at near-final positions are antioxidant stabilisers within permitted limits - these are not preservatives. Allergen Free Fragrance (synthetic, not fragrance-free) is present. Diethylamino Hydroxybenzoyl Hexyl Benzoate (Uvinul A Plus) is used here as an in-bottle retinol photostabiliser, not as a skin-applied UV filter. Cyclopentasiloxane and Dimethicone in the emulsion base have a good skin safety profile.
Encapsulated retinol via Poloxamer 235 is a meaningful delivery advance: the copolymer shell protects retinol from oxidation in storage and releases it progressively on skin...
Encapsulated retinol via Poloxamer 235 is a meaningful delivery advance: the copolymer shell protects retinol from oxidation in storage and releases it progressively on skin contact, achieving comparable efficacy to free retinol with significantly reduced irritation. EGCG from green tea at position 13 has anti-inflammatory clinical evidence relevant to the retinisation adjustment period. Niacinamide at position 19 adds independent collagen-supporting and brightening mechanisms. The emulsion base is appropriate for a retinol delivery vehicle.
Good evidence for stated claims based on public information.
Retinol at 0.15% is brand-confirmed. The Poloxamer 235 encapsulation system is disclosed on the product page - above-average transparency for an Indian brand. The '2x faster than regular retinol' claim for encapsulated delivery is based on supplier-commissioned studies, not independent peer-reviewed trials. Pregnancy contraindication is communicated on packaging.
“0.15% Retinol (Encapsulated)” Brand-confirmed; Poloxamer 235 encapsulation system disclosed.
“2x faster than regular retinol” Based on encapsulation supplier data, not an independent published trial for this formula.
“Not suitable during pregnancy” Pregnancy contraindication is communicated on packaging - correct and necessary.
No independent clinical study has been published for this formula. The '2x faster than regular retinol' claim references encapsulation technology supplier data, not an independent trial for this specific product. Retinol 0.15% is brand-confirmed. Encapsulation mechanism is disclosed.
Retinol at 0.15% is clearly stated. Pregnancy contraindication is communicated. The Poloxamer 235 encapsulation is explained. Uvinul A Plus's role as an in-bottle stabiliser (not a skin SPF) is not explained to consumers - potentially confusing given its presence in a night product.
